Injectable semaglutide has better bioavailability, researchers say, but the many patients who want an oral drug are an unmet ...

SAVANNAH Phase II trial of TAGRISSO plus savolitinib in advanced EGFRm NSCLC with high levels of MET overexpression ... treatment for patients with EGFR-mutated lung cancer across stages and ...

The analysis supports the integration of sodium-glucose cotransporter 2 (SGLT2) inhibitors into treatment paradigms for ...

Explore JANX's promising early data in prostate cancer immunotherapy. Understand market challenges, buyout rumors, and ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

Comparison of eGFR change rates before and after renal internal medical referral. Before the referral (left orange), the ...

Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...

A GFR level of 15 or less indicates kidney failure. A blockage in urine flow, such as an enlarged prostate or kidney stone, could cause kidney obstruction. This blockage can create a backup of ...

Janux Therapeutics' lead drug, JANX007, shows promising prostate cancer results with no serious side effects. Find out why ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...